Here are four things to know.
1. Centurion, which owns five manufacturing facilities in the U.S., is best known for its SorbaView Shield securement systems and Compass pressure monitoring technologies, among other medical products.
2. The deal will allow Medline to offer a full set of vascular access products to coincide with its minor procedure tray offerings and infection prevention products.
3. Centurion will continue to operate independently as a subsidiary of Medline after the acquisition.
4. Medline expects the deal to close in early December.
More articles on supply chain:
Why drugmakers would welcome Amazon’s drug market entrance
FDA approves adult treatment for lymphoma
10 most-read supply chain stories in October
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
